European equities traded in the US as American depositary receipts were rising on Thursday morning, up 0.8% to 1,325.57 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by e-commerce platform MYT (MYTE) and biotech company Evaxion (EVAX), which rose 7.2% and 7%, respectively.
They were followed by semiconductor company ASML (ASML), which added 3.3%.
The decliners from continental Europe were led by clinical-stage biopharmaceutical company Cellectis (CLLS) and telecoms and electronics company Nokia (NOK), which fell 3.7% and 3.4%, respectively.
From the UK and Ireland, the gainers were led by clinical-stage biopharmaceutical company Verona Pharma (VRNA), which jumped 6.4%, and biopharma giant GSK (GSK), which gained 1.3%.
The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and pharmaceutical company Silence Therapeutics (SLN), which lost 7.7% and 4.9%, respectively.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.